iSpecimen Inc.
ISPC
$1.25
$0.0352.88%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -6.42% | 0.74% | 3.82% | -14.45% | -4.56% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -6.42% | 0.74% | 3.82% | -14.45% | -4.56% |
| Cost of Revenue | 10.01% | 12.56% | 14.21% | -1.36% | 1.33% |
| Gross Profit | -21.92% | -9.56% | -4.82% | -24.63% | -9.52% |
| SG&A Expenses | 3.74% | -11.22% | -13.93% | -6.85% | -3.53% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.37% | -2.92% | -3.32% | -1.46% | 2.47% |
| Operating Income | -13.96% | 6.53% | 9.69% | -12.12% | -9.65% |
| Income Before Tax | -12.60% | 6.50% | 8.73% | -12.39% | -8.33% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -12.60% | 6.50% | 8.73% | -12.39% | -8.33% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -12.60% | 6.50% | 8.73% | -12.39% | -8.33% |
| EBIT | -13.96% | 6.53% | 9.69% | -12.12% | -9.65% |
| EBITDA | -13.35% | 7.95% | 10.92% | -10.87% | -8.25% |
| EPS Basic | 28.67% | 16.31% | 13.81% | -10.15% | -5.99% |
| Normalized Basic EPS | 28.68% | 16.31% | 13.81% | -10.16% | -5.99% |
| EPS Diluted | 28.67% | 16.42% | 13.91% | -10.01% | -5.85% |
| Normalized Diluted EPS | 28.68% | 16.31% | 13.81% | -10.16% | -5.99% |
| Average Basic Shares Outstanding | 57.21% | 20.28% | 7.85% | 2.02% | 2.20% |
| Average Diluted Shares Outstanding | 57.21% | 20.28% | 7.85% | 2.02% | 2.20% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |